Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

Bullboard (TSX:MBX)

View:
Comment by RazeKreationson Aug 14, 2023 7:58pm

RE:RE:RE:RE:RE:RE:RE:Q2 earnings transcript

I have added more. I think we have found the bottom. It may be a little bumpy in the short term but the longer term is shaping up to be very good.
Comment by rjc7on Aug 14, 2023 7:41pm

RE:RE:RE:RE:RE:RE:Q2 earnings transcript

You lightened the load a while back.  We're at 52 week lows so it might be a good time to average down.
Comment by RazeKreationson Aug 14, 2023 7:14pm

RE:RE:RE:RE:RE:Q2 earnings transcript

That sums it up pretty well. They may finally be on a track for substantial growth albeit it will take probably a year to see that transform into the beginnings of a stock growth run. Depending on how ...more  
Comment by wizzdumbon Aug 14, 2023 5:37pm

RE:RE:RE:RE:Q2 earnings transcript

Call was fine. My summary is that VTM is dead in the water barring some sort of miracle and that QAPs business is still looking very good but revenues coming slower than expected due to customer/FDA ...more  
Comment by rjc7on Aug 14, 2023 5:06pm

RE:RE:RE:Q2 earnings transcript

......sorry I didn't realize you cut and pasted some of it.
Comment by rjc7on Aug 14, 2023 5:04pm

RE:RE:Q2 earnings transcript

Was there suppose to be an attachment with this?
Comment by RazeKreationson Aug 14, 2023 5:01pm

RE:Q2 earnings transcript

Q3 earnings transcript. My fat fingers betrayed me
Post by RazeKreationson Aug 14, 2023 3:22pm

Q2 earnings transcript

Microbix Biosystems Inc. (OTCQX:MBXBF) Q3 2023 Results Conference Call August 14, 2023 11:00 AM ET Company Participants Deborah Honig - Investor Relations Cameron Groome - Chief Executive Officer and ...more  
Comment by lscfaon Aug 13, 2023 8:41pm

RE:KRC Update

Forward p/e => 5x, undervalued
Post by wizzdumbon Aug 11, 2023 9:16am

KRC Update

https://microbix.com/wp-content/Krugel-MBX%20-%20f2023%20Q2%20Review%20-%20FINAL%20-%202023-7-19.pdf
Comment by wizzdumbon Aug 10, 2023 5:04pm

RE:RE:When does this start factoring in.......

Well, it better be fourth quarter. My guess is it will be late and more likely Q1 2024. If it's beyond that it's a pipe dream. 
Post by RazeKreationson Aug 10, 2023 4:45pm

DxTm

What happened to all the sales of Vtm. 50 million dollars worth imported in 2019 and no one is interested in a domestic supplier? How much more inventory is going to need to be written off? Is it no ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities